CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 40 enrolled
Drug / intervention
BLI800drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04214301
NCT04214301Phase 4Completed

An Open-Label Preference Evaluation of BLI800

Braintree Laboratories·interventional·Posted Jan 2, 2020·Updated Oct 23, 2023

In Brief

A Phase 4 clinical trial evaluating BLI800 for Colonoscopy. Completed, enrolled 40 participants across 2 sites.

Detailed Summary

The purpose of this study is to evaluate patient experience ratings of BLI800 in adult patients undergoing colonoscopy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColonoscopy
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2020202120222023202420252026
First PostedJan 2, 2020
Enrollment StartSep 24, 2019
Primary CompletionNov 21, 2019
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 6.5 years ago

Interventions

BLI800drug

BLI800 Bowel Preparation